Yannuo Pharmaceutical

Pioneering advanced therapies in oncology, contrast agents, and anesthesia through innovative drug delivery platforms.

General Information
Company Name
Yannuo Pharmaceutical
Founded Year
2015
Location (Offices)
Founders / Decision Makers
Number of Employees
-
Industries
Biotechnology, Pharmaceutical
Funding Stage
Series A
Social Media

Yannuo Pharmaceutical - Company Profile

Yannuo Pharmaceutical is a high-tech enterprise focused on pioneering advanced therapies in oncology, contrast agents, and anesthesia through innovative drug delivery platforms. Established in 2015, the company specializes in the research and development of complex injections, operating three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres.

Leveraging these advanced drug delivery technologies, Yannuo Pharmaceutical concentrates on addressing clinical needs by researching and developing small molecule drugs, nucleic acid drugs, peptides, and protein drugs. With a commitment to further development and industrialization, the company focuses on therapeutic areas such as tumor treatment, contrast agents, anesthesia, and pain management.

The most recent investment in Yannuo Pharmaceutical was a Series A investment on July 7, 2023. The funding round involved investment from Zhejiang Huahai Pharmaceutical and Zhejiang Starry Pharmaceutical, indicating the interest and support of established players in the pharmaceutical industry.

Overall, Yannuo Pharmaceutical demonstrates a strong focus on leveraging advanced drug delivery technologies to address critical clinical needs in oncology and anesthesia, positioning it as an innovative player in the biotechnology and pharmaceutical industries.

Taxonomy: pharmaceuticals, drug delivery, oncology, therapeutic research, liposomes, nanoparticles, microspheres, clinical needs, small molecule drugs, nucleic acid drugs, peptide drugs, protein drugs, industrialization, tumor treatment, pain management

Funding Rounds & Investors of Yannuo Pharmaceutical (1)

View All
Funding Stage Amount No. Investors Investors Date
Series A Unknown 2 Zhejiang Starry Pharmaceutical 07 Jul 2023

Latest News of Yannuo Pharmaceutical

View All

No recent news or press coverage available for Yannuo Pharmaceutical.

Similar Companies to Yannuo Pharmaceutical

View All
Bostal Drug Delivery - Similar company to Yannuo Pharmaceutical
Bostal Drug Delivery Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals since 2013.
BeBetter Med - Similar company to Yannuo Pharmaceutical
BeBetter Med Clinical-stage drug discovery and development of advanced novel medicines for cancer and other severe illnesses.
NeoX Biotech - Similar company to Yannuo Pharmaceutical
NeoX Biotech Pioneering AI-driven advancements in immuno-oncology for groundbreaking macromolecular and multispecific drug development.
Silexon AI - Similar company to Yannuo Pharmaceutical
Silexon AI AI Empowers Drug Discovery and Life Sciences
choipharm - Similar company to Yannuo Pharmaceutical
choipharm Pioneering advancements in drug research and development, from formulation to regulatory compliance.